Because the medication itself is the same, everything in this guideincluding where to inject, how to rotate injection sites, and tips for reducing discomfortapplies whether youre taking either Zepbound or Mounjaro
Improvements in insulin sensitivity , reductions in visceral fat specifically, improvements in lipid profiles, and better glycemic control all contribute to a less inflammatory metabolic environment
Nutrient Deficiencies Eating less sometimes means eating less well
Both tirzepatide and semaglutide share a similar profile of side effects, which are mostly gastrointestinal in nature
Be alert for signs of pancreatitis, gallbladder problems, kidney problems (often related to dehydration), severe allergic reactions, and low blood sugar (hypoglycemia) if you take insulin or sulfonylureas
INFORMATION MOUNJARO 7.5mg KwikPen is a single-patient-use, multi-dose pre-filled pen containing tirzepatide a synthetic dual GIP/GLP-1 receptor agonist developed by Eli Lilly and Company Limited at a strength of 7.5mg per 0.6ml dose.[3][4] In the U.S., MOUNJARO (tirzepatide) is indicated for type 2 diabetes in adults and pediatric patients aged 10 years and older
